Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:actsOn |
norepinephrine reuptake inhibitor
dopamine reuptake inhibitor |
| gptkbp:CASNumber |
132192-21-7
|
| gptkbp:developedBy |
antidepressant
|
| gptkbp:hasInChIKey |
gptkb:QJQJQJQJQJQJQJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C21H31ClN2O
|
| gptkbp:hasSMILES |
C1CCC(CC1)CN2CCN(CC2)CCCC(=O)C3=CC=C(C=C3)Cl
|
| https://www.w3.org/2000/01/rdf-schema#label |
SCl 158
|
| gptkbp:IUPACName |
1-(4-chlorophenyl)-4-(4-cyclohexylmethylpiperazin-1-yl)butan-1-one
|
| gptkbp:legalStatus |
uncontrolled
|
| gptkbp:molecularWeight |
362.94 g/mol
|
| gptkbp:PubChem_CID |
178222
|
| gptkbp:was_investigated_for |
gptkb:major_depressive_disorder
|
| gptkbp:was_not_marketed |
true
|
| gptkbp:bfsParent |
gptkb:Corona_Borealis_Supercluster
|
| gptkbp:bfsLayer |
8
|